SEC Form 4 · accession 0001193125-26-355407
Marex Group Ltd · MRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rob Irvin
Officer — Chief Financial Officer · Director
Period of report
Aug 14, 2026
Accepted (ET)
Aug 18, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001997464
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F3 | Aug 14, 2026 | S | 3,500 | $70.9064 | D | 31,246 | D | |
| Ordinary SharesF2,F3 | Aug 14, 2026 | S | 200 | $71.865 | D | 31,046 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.